Related references
Note: Only part of the references are listed.Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacy
Madhav Desai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies
Jorge J. Castillo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
Brian J. Lannutti et al.
BLOOD (2011)
Pathogenesis of Non-Hodgkin's Lymphoma
Hendrik Nogai et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma
P. M. Bhende et al.
LEUKEMIA (2010)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Phosphatidylinositol 3′-Kinase Catalytic Subunit α Gene Amplification Contributes to the Pathogenesis of Mantle Cell Lymphoma
Amanda Psyrri et al.
CLINICAL CANCER RESEARCH (2009)
Dok-4 Is a Novel Negative Regulator of T Cell Activation
Audrey Gerard et al.
JOURNAL OF IMMUNOLOGY (2009)
Analysis of Signaling Events by Dynamic Phosphoflow Cytometry
Guylene Firaguay et al.
SCIENCE SIGNALING (2009)
PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma
J. Abubaker et al.
LEUKEMIA (2007)
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten et al.
NATURE (2007)
Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival
Shahab Uddin et al.
BLOOD (2006)
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
Martina Rudelius et al.
BLOOD (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Constitutive phosphoinositide 3-kinase activation in acute myeloid leukemia is not due to p110δ mutations
P Cornillet-Lefebvre et al.
LEUKEMIA (2006)
Oncogenic PI3K and its role in cancer
Y Samuels et al.
CURRENT OPINION IN ONCOLOGY (2006)
Oncogenic PI3K deregulates transcription and translation
AG Bader et al.
NATURE REVIEWS CANCER (2005)
Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma
C Gulmann et al.
CLINICAL CANCER RESEARCH (2005)
PHLPP: A phosphatase that directly dephosphorylates akt, promotes apoptosis, and suppresses tumor growth
TY Gao et al.
MOLECULAR CELL (2005)
Frequent genetic and biochemical alterations of the PI3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma
JMG Pedrero et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray
HB Zha et al.
LABORATORY INVESTIGATION (2004)
Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression
PP Massion et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Mutation of the PIK3CA gene in ovarian and breast cancer
IG Campbell et al.
CANCER RESEARCH (2004)
PI3K-Akt pathway: Its functions and alterations in human cancer
M Osaki et al.
APOPTOSIS (2004)
Oncogenic mutations of PIK3CA in human cancers
Y Samuels et al.
CELL CYCLE (2004)
Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable
YH Min et al.
LEUKEMIA (2003)
Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIk3CA amplification in gastric carcinoma
DS Byun et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation
E Clayton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Expression of a mutated form of the p85α regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO)
M Jücker et al.
LEUKEMIA (2002)
PIK3CA as an oncogene in cervical cancer
YY Ma et al.
ONCOGENE (2000)
Share Paper
